Physician

Abdul Ali, M.D.

According to 2025 Medicare claims, Abdul Ali, M.D. (NPI: 1598734121) practices cardiology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Harris, TX. This provider's primary affiliated billing organization is ABDUL ALI,M.D.P.A. (NPI: 1518929256; TIN: 742136837) and primary practice location at 77008-3907.

Ali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 276 traditional Medicare patients, billed 3,299 HCPCS/CPT codes, and received $207,772 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 2,557 prescription claims across 385 beneficiaries totaling $345,064 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 12 claims. Open Payments data shows 34 records totaling $1,031. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $357,278 to $207,772. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $247,424 and ending at $345,064. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $34,785 and ending at $30,539.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	728	4,813	$357,278
2016	686	4,456	$314,128
2017	612	4,176	$269,791
2018	505	3,789	$243,625
2019	453	3,191	$207,064
2020	319	1,839	$118,181
2021	262	1,823	$107,615
2022	281	2,707	$156,682
2023	325	3,911	$245,461
2024	276	3,299	$207,772

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	338	3,545	$247,424
2016	350	3,481	$236,152
2017	318	2,697	$201,587
2018	242	1,727	$144,669
2019	205	841	$110,043
2020	331	1,914	$266,459
2021	329	2,040	$345,765
2022	280	1,725	$274,494
2023	354	2,251	$336,357
2024	385	2,557	$345,064

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	61	311	$29,850
2016	52	203	$3,745
2017	N/R	54	$1,437
2018	N/R	62	$1,439
2019	N/R	29	$545
2020	N/R	38	$608
2021	N/R	29	$39,486
2022	N/R	63	$34,432
2023	N/R	12	$30,195
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	161	190	$104
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	180	197	$78
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	171	2,169	$63
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	73	108	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	144	188	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	58	3,141	$59,689
Entresto	Sacubitril/Valsartan	51	2,320	$51,464
Xarelto	Rivaroxaban	51	2,730	$50,168
Jardiance	Empagliflozin	15	1,170	$23,443
Vascepa	Icosapent Ethyl	28	1,860	$22,256

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	34	$1,031	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdul Ali, M.D.?

Tedicare shows public-source Medicare data for Abdul Ali, M.D. (NPI 1598734121), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdul Ali, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abdul Ali, M.D.?

Abdul Ali, M.D. is linked to ABDUL ALI,M.D.P.A. (billing NPI 1518929256) in the available physician profile data.

Does Abdul Ali, M.D. have Open Payments data?

Abdul Ali, M.D. has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.